Total planned funding: $181,878,289
Allocations
Countries/Regions
Ukraine | $181,878,289 |
Organizational Types
Unknown | $48,270,995 |
NGO | $40,069,379 |
Private Contractor | $35,793,894 |
Own Agency | $24,407,990 |
Multi-lateral Agency | $12,925,607 |
University | $10,677,000 |
Implementing Agency | $5,300,000 |
Other USG Agency | $4,183,424 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $76,281,041 |
Treatment | $36,646,118 |
Testing | $21,431,487 |
Prevention | $17,110,851 |
Management and Operations | $16,487,573 |
Care | $13,921,219 |
Budget Codes
OHSS: Health Systems Strengthening | $42,913,615 |
HTXS: Treatment: Adult Treatment | $24,082,123 |
HVCT: Testing: HIV Testing and Counseling | $21,431,487 |
HVSI: Strategic Information | $20,641,866 |
HVMS: Management and Operations | $16,487,573 |
HLAB: Laboratory Infrastructure | $12,725,560 |
HTXD: Treatment: ARV Drugs | $12,563,995 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $8,423,385 |
HVTB: Care: TB/HIV | $7,429,294 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,089,383 |
HBHC: Care: Adult Care and Support | $4,348,732 |
HKID: Care: Orphans and Vulnerable Children | $2,143,193 |
HMBL: Biomedical Prevention: Blood Safety | $1,887,636 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $167,090 |
PDCS: Care: Pediatric Care and Support | $0 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
PDTX: Treatment: Pediatric Treatment | $0 |
Top Partner Programs
Not Available:
$44,500,995
Countries/Regions
Chemonics International:
$20,772,383
Countries/Regions
USG Aggregated Agencies:
$18,453,667
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions